| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-4,177 | -7,117 | -13,108 | -17,089 | -16,845 | -13,791 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization expense | ||||||||
2,554 | 2,186 | 1,980 | 1,734 | 1,528 | 1,341 | 0 | 0 | 0 |
Stock-based compensation expense | ||||||||
14,511 | 12,721 | 12,502 | 11,819 | 9,304 | 7,121 | 0 | 0 | 0 |
Noncash interest expense | ||||||||
- | - | - | - | - | 14 | 0 | 0 | 0 |
Provision for bad debt | ||||||||
0 | - | - | - | - | - | - | - | - |
Deferred rent | ||||||||
192 | 135 | 61 | 10 | -195 | -337 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
10,298 | 15,232 | 8,598 | 6,850 | 5,679 | 2,766 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||||
5,861 | 5,609 | 1,565 | -543 | 420 | 863 | 0 | 0 | 0 |
Other assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Accounts payable | ||||||||
6,189 | 6,837 | 9,070 | 3,268 | 6,952 | 4,932 | 0 | 0 | 0 |
Accrued expenses and other current liabilities | ||||||||
8,597 | 10,126 | 3,371 | 814 | -111 | 1,324 | 0 | 0 | 0 |
Deferred revenue | ||||||||
-93 | 61 | 0 | 0 | 0 | - | - | - | - |
Deferred revenue | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net cash provided by (used in) operating activities | ||||||||
11,822 | 4,413 | 4,566 | -4,740 | -4,536 | -1,897 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Acquisition of property and equipment, including costs capitalized for development of internal-use software | ||||||||
3,193 | 2,975 | 3,390 | 3,825 | 3,681 | 3,668 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||
-3,193 | -2,975 | -3,390 | -3,825 | -3,681 | -3,668 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | ||||||||
4,112 | 2,982 | 2,064 | 1,167 | 527 | 861 | 0 | 0 | 0 |
Proceeds from borrowings on line of credit | ||||||||
- | - | - | - | - | 22,729 | 0 | 0 | 0 |
Repayments of borrowings on line of credit | ||||||||
- | - | - | - | - | 24,729 | 0 | 0 | 0 |
Repayments of term loan | ||||||||
- | - | - | - | - | 2,625 | 0 | 0 | 0 |
Payments of initial public offering costs | ||||||||
- | - | - | - | - | 3,713 | 0 | 0 | 0 |
Net cash provided by financing activities | ||||||||
4,112 | 2,982 | 2,064 | 43,306 | 43,357 | 44,836 | 0 | 0 | 0 |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||||
12,741 | 4,420 | 3,240 | 34,741 | 35,140 | 39,271 | 0 | 0 | 0 |
Supplemental disclosure of noncash investing and financing information: | ||||||||
Deferred initial public offering costs included in accounts payable or accrued expenses | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Accretion of redeemable convertible preferred stock to redemption value | ||||||||
- | - | - | - | - | 37,415 | 0 | 0 | 0 |